SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1581>>Groups revise guidelines on anemia drug use Mon Oct 22, 2007 3:00pm EDT tuck-10/22/2007
1580FDA Backs Medicare Curbs on Anemia Drugs Posted by Jacob Goldstein October 17,Doc Bones-10/18/2007
1579Amgen boosts capital lobbying [LAT] The company spends more to state its case aDoc Bones-10/18/2007
1578Amgen Defends Its Turf as Competition Looms for Anemia Drug [NYT] By ANDREW POLDoc Bones-10/17/2007
1577Amgen: Quick Comment: FDA Backs CMS; Negative for Amgen MORGAN 2007-10-16 11:23mopgcw-10/17/2007
1576DrugWonks' Robert Goldberg on the ongoing fight over the CMS guidelines: drtuck-10/11/2007
1575Baird has learned that the lead drug obtained from the Ilypsa munch will not go tuck-9/26/2007
1574Thanks Tuck..eomzeta1961-9/25/2007
1573Amgen: Correction: '08 Will Be... MORGAN STANLEY RESEARCH 2007-09-24 12:37 (mopgcw-9/25/2007
1572Medicare Says Anemia Rule Likely to Stand REUTERS NEWS SERVICE September 25, 20Doc Bones-9/25/2007
1571According to one report I have seen, there was an imbalance in cancer incidence tuck-9/24/2007
1570Tuck, thanks so much for this(and all the info you collate for us on these threazeta1961-9/24/2007
1569Denosumab in RA patients: 12 month BMD data >>Title: Denosumab Increases tuck-9/24/2007
1568>>Amgen drug increased bone density in trial Wed Sep 19, 2007 7:50pm EDT tuck-9/24/2007
1567ML A revision of the NCD could boost Aranesp revenues $500M We believe CMS is ltom pope-9/24/2007
1566>>Vectibix™ (panitumumab) Receives Positive Opinion for Marketing Authoriztuck-9/21/2007
1565Amgen: Strong Reclast Data Raise the Bar Modestly MORGAN STANLE 2007-09-18 10:32mopgcw-9/18/2007
1564The Dialysis Business: Fair Treatment? [NYT] By ANDREW POLLACK El Segundo, CaliDoc Bones-9/17/2007
1563Missed this one when it came out on 9/12 - ML: Upgrading to BUY with $67 targettom pope-9/14/2007
1562UBS upgraded Price target to $61.Keith Feral-9/12/2007
1561FDA Panel Vote Is a Win for Amgen, J&J Decision Over Doses For Anemia DrugsDoc Bones-9/12/2007
1560Oh, I'll have to wit for my wife to come home this evening. They're brosteve kammerer-9/11/2007
1559Steve, it's live here but you have to pay $140.. secure.iian.ibeam.comzeta1961-9/11/2007
1558The FDA CRDAC Meeting on September 11, 2007 is being broadcast live somewhere. steve kammerer-9/11/2007
1557CRDAC briefing document: To save some difficult surfing for those interested, hetuck-9/10/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News